An Italian coronavirus vaccine
developed by the Takis company has antibodies generated in mice
that work on human cells, according to tests carried out at
Rome's infectious-disease Spallanzani Hospital, Takis CEO Luigi
Aurisicchio told ANSA Monday.
He said that for the first time in the world a COVID-19
candidate vaccine has neutralized the virus in human cells.
This is the most advanced stage of testing of a candidate
vaccine created in Italy, he said.
He said hat human tests are expected after this summer.
ALL RIGHTS RESERVED © Copyright ANSA
